Header Logo

Jennifer LaFemina

Concepts (183)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Internship and Residency
11
2024
746
3.380
Why?
Pancreatic Neoplasms
11
2017
331
1.940
Why?
General Surgery
4
2024
191
1.620
Why?
Breast Neoplasms
6
2024
1118
1.520
Why?
Pancreatitis
3
2020
95
1.240
Why?
Carcinoma, Pancreatic Ductal
7
2015
106
1.020
Why?
Education, Medical, Graduate
5
2024
317
0.980
Why?
Pancreatectomy
5
2016
96
0.970
Why?
Endrin
1
2024
2
0.900
Why?
Mastectomy
3
2024
52
0.880
Why?
Nerve Block
1
2024
41
0.850
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2019
26
0.630
Why?
Social Media
1
2021
117
0.630
Why?
Venous Thromboembolism
1
2020
141
0.610
Why?
Databases, Factual
2
2019
813
0.590
Why?
Venous Thrombosis
1
2019
110
0.580
Why?
Students, Medical
1
2020
245
0.560
Why?
Humans
36
2024
59360
0.530
Why?
Exocrine Pancreatic Insufficiency
1
2016
7
0.520
Why?
Pancreas, Exocrine
1
2016
12
0.510
Why?
Retrospective Studies
14
2024
6071
0.510
Why?
Hemangioma
1
2016
28
0.500
Why?
Pancreaticoduodenectomy
1
2016
62
0.500
Why?
Pancreatitis, Chronic
1
2015
19
0.500
Why?
Carcinoma, Renal Cell
1
2016
83
0.480
Why?
Kidney Neoplasms
1
2016
126
0.460
Why?
Genetic Testing
1
2015
126
0.460
Why?
Islets of Langerhans
1
2016
271
0.450
Why?
Postoperative Complications
2
2019
1202
0.430
Why?
Clinical Competence
4
2024
683
0.430
Why?
Adenocarcinoma, Mucinous
4
2015
30
0.430
Why?
Liver Neoplasms
1
2016
277
0.420
Why?
Nerve Sheath Neoplasms
1
2012
5
0.410
Why?
Neoplasms, Radiation-Induced
1
2012
27
0.400
Why?
Adrenal Cortex Neoplasms
1
2012
4
0.400
Why?
Neurofibromatosis 1
1
2012
28
0.390
Why?
Female
20
2024
30705
0.360
Why?
Burnout, Professional
2
2023
125
0.350
Why?
Surveys and Questionnaires
5
2023
2513
0.340
Why?
Stomach
1
2010
83
0.330
Why?
Carcinoma, Papillary
3
2015
35
0.330
Why?
Pancreas
1
2010
147
0.320
Why?
Suture Techniques
1
2010
91
0.320
Why?
Hospital Units
1
2008
8
0.300
Why?
Gallstones
1
2008
24
0.300
Why?
Hospital Costs
1
2008
119
0.280
Why?
Follow-Up Studies
5
2019
2337
0.270
Why?
Risk Factors
5
2019
4984
0.270
Why?
Patient Admission
1
2008
184
0.270
Why?
Middle Aged
12
2019
16317
0.250
Why?
Internal Medicine
2
2023
154
0.250
Why?
Cohort Studies
4
2022
2374
0.250
Why?
Male
16
2023
27739
0.240
Why?
Specialty Boards
1
2024
13
0.230
Why?
United States
6
2024
7390
0.230
Why?
Radiotherapy, Adjuvant
2
2016
58
0.230
Why?
Chemotherapy, Adjuvant
2
2016
75
0.220
Why?
Feedback
1
2023
87
0.210
Why?
Pain, Postoperative
1
2024
141
0.200
Why?
Educational Measurement
1
2024
211
0.200
Why?
Pandemics
3
2023
615
0.200
Why?
Preoperative Care
3
2019
180
0.200
Why?
Aged, 80 and over
6
2016
5128
0.200
Why?
Prognosis
4
2019
1600
0.180
Why?
Motivation
1
2023
273
0.180
Why?
Neoplasm Recurrence, Local
2
2013
300
0.180
Why?
Cross-Sectional Studies
3
2023
2373
0.180
Why?
Robotic Surgical Procedures
1
2023
115
0.180
Why?
Aged
10
2017
13416
0.170
Why?
Pilot Projects
1
2023
914
0.170
Why?
Canada
1
2020
147
0.170
Why?
Multivariate Analysis
3
2013
902
0.170
Why?
Statistics, Nonparametric
2
2012
206
0.170
Why?
Adult
9
2023
15669
0.170
Why?
Risk Assessment
3
2020
1921
0.170
Why?
Veins
1
2020
61
0.170
Why?
Treatment Outcome
5
2017
5284
0.170
Why?
Inservice Training
1
2020
81
0.170
Why?
Surgical Oncology
1
2019
2
0.170
Why?
Research Design
1
2023
555
0.160
Why?
Certification
1
2019
45
0.160
Why?
Young Adult
3
2016
4267
0.160
Why?
Analgesics, Opioid
1
2024
483
0.160
Why?
Incidence
2
2019
1237
0.150
Why?
Education, Medical, Continuing
1
2019
95
0.150
Why?
Learning
1
2020
169
0.150
Why?
Postoperative Hemorrhage
1
2019
37
0.150
Why?
Hepatectomy
1
2019
60
0.150
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2017
14
0.150
Why?
Carcinoma, Neuroendocrine
1
2017
11
0.150
Why?
Kaplan-Meier Estimate
3
2015
396
0.140
Why?
Mutation
4
2015
2456
0.140
Why?
Lung Neoplasms
1
2023
582
0.140
Why?
Lymphoscintigraphy
1
2016
6
0.130
Why?
Sentinel Lymph Node
1
2016
9
0.130
Why?
Methylene Blue
1
2016
22
0.130
Why?
Sentinel Lymph Node Biopsy
1
2016
38
0.130
Why?
Curriculum
1
2020
558
0.130
Why?
Coloring Agents
1
2016
53
0.130
Why?
Anticoagulants
1
2020
477
0.130
Why?
Neoplasm, Residual
2
2013
38
0.130
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2015
12
0.120
Why?
Diet
1
2019
497
0.120
Why?
Multidetector Computed Tomography
1
2014
20
0.120
Why?
ras Proteins
1
2015
77
0.120
Why?
Quality Improvement
1
2019
416
0.110
Why?
Time Factors
3
2019
3617
0.110
Why?
Hypoglycemic Agents
1
2016
192
0.110
Why?
Nomograms
1
2013
12
0.110
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2013
4
0.110
Why?
Proto-Oncogene Proteins
1
2015
318
0.100
Why?
Carcinoma in Situ
1
2013
32
0.100
Why?
Melanoma
1
2016
329
0.100
Why?
Early Detection of Cancer
1
2015
266
0.100
Why?
Neoadjuvant Therapy
1
2012
72
0.100
Why?
New England
2
2023
267
0.100
Why?
Confidence Intervals
1
2012
241
0.100
Why?
Neoplasm Metastasis
1
2012
188
0.100
Why?
Genetic Predisposition to Disease
1
2015
676
0.090
Why?
Biomarkers, Tumor
1
2015
461
0.090
Why?
Skin Neoplasms
1
2016
404
0.090
Why?
Proportional Hazards Models
1
2012
674
0.090
Why?
Adolescent
2
2012
5824
0.090
Why?
Adenocarcinoma, Papillary
1
2010
9
0.090
Why?
Pancreatic Fistula
1
2010
18
0.090
Why?
Survival Rate
1
2012
802
0.080
Why?
Health Care Costs
1
2012
203
0.080
Why?
Anastomosis, Surgical
1
2010
107
0.080
Why?
Carrier State
1
2009
17
0.080
Why?
Neoplasms
1
2019
1240
0.080
Why?
Logistic Models
2
2013
1232
0.080
Why?
Siblings
1
2009
41
0.080
Why?
Pedigree
1
2009
183
0.080
Why?
Cholangiography
1
2008
42
0.080
Why?
Cholecystectomy
1
2008
31
0.080
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2008
46
0.070
Why?
Medicare
1
2012
598
0.070
Why?
Linear Models
1
2008
402
0.070
Why?
Family
1
2009
229
0.070
Why?
Cost-Benefit Analysis
1
2008
297
0.070
Why?
Alcohol Drinking
1
2009
288
0.070
Why?
Cell Line, Tumor
1
2010
1370
0.060
Why?
Quality Indicators, Health Care
1
2008
332
0.060
Why?
Patient Readmission
1
2008
420
0.060
Why?
Nipples
1
2023
14
0.050
Why?
Disease Models, Animal
1
2010
2050
0.050
Why?
Proto-Oncogene Proteins p21(ras)
2
2015
55
0.050
Why?
Income
1
2023
156
0.050
Why?
Tomography, X-Ray Computed
1
2009
1526
0.050
Why?
Personnel Selection
1
2022
50
0.050
Why?
Self Report
1
2023
359
0.050
Why?
Mastectomy, Segmental
1
2021
45
0.040
Why?
Students
1
2022
202
0.040
Why?
Mammography
1
2021
269
0.040
Why?
Neoplasm Grading
1
2017
79
0.040
Why?
Ki-67 Antigen
1
2017
34
0.040
Why?
Lung
1
2023
919
0.040
Why?
Lymphatic Metastasis
1
2016
74
0.030
Why?
Mice
1
2010
10292
0.030
Why?
Chromogranins
1
2015
12
0.030
Why?
Oncogene Proteins
1
2015
31
0.030
Why?
Body Mass Index
1
2019
831
0.030
Why?
Observer Variation
1
2014
205
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2015
263
0.030
Why?
Ubiquitin-Protein Ligases
1
2015
210
0.030
Why?
Neoplasm Invasiveness
1
2013
250
0.030
Why?
Chi-Square Distribution
1
2013
409
0.020
Why?
Neoplasm Staging
1
2013
452
0.020
Why?
SEER Program
1
2012
66
0.020
Why?
Diagnosis, Differential
1
2014
937
0.020
Why?
Sensitivity and Specificity
1
2014
1093
0.020
Why?
Health Services
1
2012
81
0.020
Why?
Population Surveillance
1
2012
194
0.020
Why?
Veratrum Alkaloids
1
2010
9
0.020
Why?
Disease Progression
1
2015
1122
0.020
Why?
Reproducibility of Results
1
2014
1561
0.020
Why?
Genes, Tumor Suppressor
1
2010
70
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
178
0.020
Why?
Hedgehog Proteins
1
2010
109
0.020
Why?
DNA-Binding Proteins
1
2015
1151
0.020
Why?
Prospective Studies
1
2013
3067
0.020
Why?
Hospitalization
1
2012
1290
0.010
Why?
Animals
1
2010
19651
0.010
Why?
LaFemina's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (183)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_